2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

[1]  I. Hirsch,et al.  The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2021, Diabetes Care.

[2]  S. Saydah,et al.  Increase in Prevalence of Diabetic Ketoacidosis at Diagnosis Among Youth With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study , 2021, Diabetes Care.

[3]  A. Jatoi,et al.  Rare Adverse Events with Programmed Death-1 and Programmed Death-1 Ligand Inhibitors: Justification and Rationale for a Systematic Review , 2021, Current Oncology Reports.

[4]  A. Dyer,et al.  One Step or Two Step Testing for Gestational Diabetes: Which Is Best? , 2021, American journal of obstetrics and gynecology.

[5]  David Alfego,et al.  Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis , 2021, PloS one.

[6]  N. T. Dung,et al.  Serum hs-CRP measured prior transplantation predicts of new-onset diabetes after transplantation in renal transplant recipients. , 2021, Transplant immunology.

[7]  B. Marks,et al.  Post-Transplantation Diabetes Mellitus in Pediatric Patients , 2021, Hormone Research in Paediatrics.

[8]  J. Buse,et al.  Carbohydrate Intake Prior to Oral Glucose Tolerance Testing , 2021, Journal of the Endocrine Society.

[9]  Cheng-Chang Lu,et al.  Hemoglobin A1c Levels Associated with Age and Gender in Taiwanese Adults without Prior Diagnosis with Diabetes , 2021, International journal of environmental research and public health.

[10]  Shyang-Rong Shih,et al.  Different cutoffs of hypertension, risk of incident diabetes and progression of insulin resistance: A prospective cohort study. , 2021, Journal of the Formosan Medical Association = Taiwan yi zhi.

[11]  Lee Ann Fullington,et al.  HbA1c Performance in African Descent Populations in the United States With Normal Glucose Tolerance, Prediabetes, or Diabetes: A Scoping Review , 2021, Preventing chronic disease.

[12]  T. Hillier,et al.  A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening. , 2021, The New England journal of medicine.

[13]  K. Herold,et al.  Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals , 2021, Science Translational Medicine.

[14]  E. Gregg,et al.  Progression to diabetes by baseline glycemic status among middle-aged and older adults in the United States, 2006-2014. , 2021, Diabetes research and clinical practice.

[15]  I. Beń-Skowronek IPEX Syndrome: Genetics and Treatment Options , 2021, Genes.

[16]  A. Dyer,et al.  Newborn Adiposity and Cord Blood C-Peptide as Mediators of the Maternal Metabolic Environment and Childhood Adiposity , 2021, Diabetes Care.

[17]  M. Petrov,et al.  diagnosis of endocrine disease: Diagnosing and classifying diabetes in diseases of the exocrine pancreas. , 2021, European journal of endocrinology.

[18]  D. Heimburger,et al.  Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study , 2020, PloS one.

[19]  M. Rewers,et al.  Incidence and Predictors of Type 1 Diabetes among Younger Adults Aged 20-45 Years: The Diabetes in Young Adults (DiYA) Study. , 2020, Diabetes research and clinical practice.

[20]  B. Chung,et al.  Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial , 2020, Annals of transplantation.

[21]  X. Bao,et al.  Autoimmune polyendocrine syndrome induced by immune checkpoint inhibitors: a systematic review , 2020, Cancer Immunology, Immunotherapy.

[22]  P. Ritz,et al.  Diabetes Remission and Relapse After Bariatric Surgery: a Nationwide Population-Based Study , 2020, Obesity Surgery.

[23]  K. Schechtman,et al.  Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes. , 2020, The New England journal of medicine.

[24]  Abdulaziz A. Alodhayani,et al.  Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes , 2020, PloS one.

[25]  R. Blackstone,et al.  Outcomes in Bariatric and Metabolic Surgery: an Updated 5-Year Review , 2020, Current Obesity Reports.

[26]  Krista K. Proia,et al.  Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review , 2020, Diabetes Care.

[27]  M. McCarthy,et al.  Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2020, Diabetes Care.

[28]  Lauric A. Ferrat,et al.  Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults , 2020, Diagnostic and Prognostic Research.

[29]  Martin T. Wells,et al.  Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. , 2020, The lancet. Diabetes & endocrinology.

[30]  Ming-Ju Wu,et al.  Risk Factors in and Long-Term Survival of Patients with Post-Transplantation Diabetes Mellitus: A Retrospective Cohort Study , 2020, International journal of environmental research and public health.

[31]  R. Goland,et al.  C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet , 2020, Diabetes Care.

[32]  R. Mori,et al.  Economic Evaluations of Gestational Diabetes Mellitus Screening: A Systematic Review , 2020, Journal of epidemiology.

[33]  M. Rewers,et al.  Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado , 2020, Diabetes Care.

[34]  R. Hummelen,et al.  Early Gestational Diabetes Mellitus Screening With Glycated Hemoglobin: A Systematic Review. , 2020, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[35]  M. Monami,et al.  Metabolic surgery for the treatment of type 2 diabetes: A network meta‐analysis of randomized controlled trials , 2020, Diabetes, obesity & metabolism.

[36]  K. Khunti,et al.  Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes , 2020, BMJ Open Diabetes Research & Care.

[37]  J. Nelson,et al.  Reproducibility of a prediabetes classification in a contemporary population , 2020, Metabolism open.

[38]  J. McNamara,et al.  The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: A CF patient registry study. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[39]  Z. Nachum,et al.  Markers for undiagnosed type 2 diabetes mellitus during pregnancy—A population‐based retrospective cohort study , 2020, Journal of diabetes.

[40]  M. Mei-Zahav,et al.  Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[41]  C. Y. Ooi,et al.  Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[42]  E. Bonifacio,et al.  Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany. , 2020, JAMA.

[43]  Y. Bozkuş,et al.  Analysis of Risk Factors for Posttransplant Diabetes Mellitus After Kidney Transplantation: Single-Center Experience. , 2020, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[44]  A. Hattersley,et al.  De Novo Mutations in EIF2B1 Affecting eIF2 Signaling Cause Neonatal/Early-Onset Diabetes and Transient Hepatic Dysfunction , 2019, Diabetes.

[45]  P. W. Wilson,et al.  Impact of mismatches in HbA1c vs glucose values on the diagnostic classification of diabetes and prediabetes , 2019, Diabetic medicine : a journal of the British Diabetic Association.

[46]  Tao Yang,et al.  Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function , 2019, Diabetes & metabolism journal.

[47]  S. Saghafian,et al.  Incidence, Risk Factors, and Trends for Postheart Transplantation Diabetes Mellitus. , 2019, The American journal of cardiology.

[48]  S. K. Puri,et al.  Dental clinic: Potential source of high-risk screening for prediabetes and type 2 diabetes , 2019, Indian journal of dental research : official publication of Indian Society for Dental Research.

[49]  L. Pyle,et al.  Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Colorado Children, 2010–2017 , 2019, Diabetes Care.

[50]  Huixia Yang,et al.  Preconception diabetes mellitus and adverse pregnancy outcomes in over 6.4 million women: A population-based cohort study in China , 2019, PLoS medicine.

[51]  B. Shields,et al.  Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years , 2019, BMJ Open.

[52]  P. McKeigue,et al.  Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes , 2019, BMC Medicine.

[53]  J. Egan,et al.  Post-transplant diabetes mellitus associated with heart and lung transplant , 2019, Irish Journal of Medical Science (1971 -).

[54]  I. Godsland,et al.  Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: an ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) Study Analysis. , 2019, Diabetes research and clinical practice.

[55]  S. Mudaliar,et al.  Does diabetes prevention translate into reduced long-term vascular complications of diabetes? , 2019, Diabetologia.

[56]  J. Krischer,et al.  An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. , 2019, The New England journal of medicine.

[57]  L. Philipson,et al.  GCK-MODY in the US Monogenic Diabetes Registry: Description of 27 unpublished variants. , 2019, Diabetes research and clinical practice.

[58]  Angela M Rodrigues,et al.  Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. , 2019, The lancet. Diabetes & endocrinology.

[59]  B. Shields,et al.  Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes , 2019, Diabetologia.

[60]  D. Nathan,et al.  Accuracy of a Point-of-Care Hemoglobin A1c Assay , 2019 .

[61]  D. Benaiges,et al.  Association of first-trimester HbA1c levels with adverse pregnancy outcomes in different ethnic groups. , 2019, Diabetes research and clinical practice.

[62]  M. Skopkova,et al.  Novel insights into genetics and clinics of the HNF1A-MODY , 2019, Endocrine regulations.

[63]  L. Barbour,et al.  Universal early pregnancy glycosylated hemoglobin A1c as an adjunct to Carpenter-Coustan screening: an observational cohort study. , 2019, American journal of obstetrics & gynecology MFM.

[64]  J. Gilmour Response to the Letter to the Editor From Dr. Boudreau et al, "Validation of a Stepwise Approach Using Glycated Hemoglobin Levels to Reduce the Number of Required Oral Glucose Tolerance Tests to Screen for Cystic Fibrosis-Related Diabetes in Adults". , 2019, Canadian journal of diabetes.

[65]  E. Etchells,et al.  Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels. , 2019, Canadian journal of diabetes.

[66]  K. Vehik,et al.  Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children , 2019, Pediatric diabetes.

[67]  A. Dyer,et al.  Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism , 2019, Diabetes Care.

[68]  A. Dyer,et al.  Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism , 2019, Diabetes Care.

[69]  S. Shortreed,et al.  Early Pregnancy Hemoglobin A1C and Pregnancy Outcomes: A Population-Based Study , 2018, American Journal of Perinatology.

[70]  N. White,et al.  Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association , 2018, Diabetes Care.

[71]  T. Masui,et al.  Current state and future evolution of pancreatic islet transplantation , 2018, Annals of gastroenterological surgery.

[72]  C. Acerini,et al.  ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis‐related diabetes in children and adolescents , 2018, Pediatric diabetes.

[73]  G. Saccone,et al.  Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[74]  A. Dyer,et al.  Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity , 2018, JAMA.

[75]  S. Grant,et al.  A Global Perspective of Latent Autoimmune Diabetes in Adults , 2018, Trends in Endocrinology & Metabolism.

[76]  D. Simmons,et al.  Ethnic Disparities in Gestational Diabetes , 2018, Current Diabetes Reports.

[77]  Mark S. Anderson,et al.  Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors , 2018, Diabetes.

[78]  J. Coresh,et al.  Prognostic Implications of Single-Sample Confirmatory Testing for Undiagnosed Diabetes , 2018, Annals of Internal Medicine.

[79]  J. Crandell,et al.  Racial/Ethnic Disparities in Diabetes Diagnosis and Glycemic Control Among Women of Reproductive Age. , 2018, Journal of women's health.

[80]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. , 2018, Diabetes research and clinical practice.

[81]  J. Eriksson,et al.  Effects of a Lifestyle Intervention During Pregnancy and First Postpartum Year: Findings From the RADIEL Study , 2018, The Journal of clinical endocrinology and metabolism.

[82]  E. Mayer-Davis,et al.  Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998–2013: A Retrospective Cohort Study , 2018, Diabetes Care.

[83]  Denise V. D’Angelo,et al.  Disparities in Preconception Health Indicators — 
Behavioral Risk Factor Surveillance System, 2013–2015, and Pregnancy Risk Assessment Monitoring System, 2013–2014 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[84]  Roy Taylor,et al.  Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial , 2017, The Lancet.

[85]  J. Catov,et al.  Early Pregnancy Diabetes Screening and Diagnosis: Prevalence, Rates of Abnormal Test Results, and Associated Factors. , 2017, Obstetrics and gynecology.

[86]  D. Simmons,et al.  Screening and Treatment for Early-Onset Gestational Diabetes Mellitus: a Systematic Review and Meta-analysis , 2017, Current Diabetes Reports.

[87]  R. Buzzetti,et al.  Adult-onset autoimmune diabetes: current knowledge and implications for management , 2017, Nature Reviews Endocrinology.

[88]  Christian Gieger,et al.  Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis , 2017, PLoS Medicine.

[89]  A. Paterson HbA1c for type 2 diabetes diagnosis in Africans and African Americans: Personalized medicine NOW! , 2017, PLoS medicine.

[90]  Simon de Lusignan,et al.  Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study , 2017, Diabetes Care.

[91]  E. Barrett-Connor,et al.  Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS) , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[92]  J. Wyckoff,et al.  Application of One-Step IADPSG Versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on Health Services, Clinical Care, and Outcomes , 2017, Current Diabetes Reports.

[93]  E. Dirinck,et al.  Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population , 2017, International Journal of Obesity.

[94]  R. Beck,et al.  Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels. , 2017, Annals of internal medicine.

[95]  B. Shields,et al.  Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients , 2017, Diabetes Care.

[96]  A. Avogaro,et al.  SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System , 2017, Diabetologia.

[97]  M. Korc,et al.  Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer , 2017, Diabetes.

[98]  K. Guelfi,et al.  A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women , 2017, American journal of obstetrics and gynecology.

[99]  R. Ozaki,et al.  In Utero Exposure to Maternal Hyperglycemia Increases Childhood Cardiometabolic Risk in Offspring , 2017, Diabetes Care.

[100]  Vikesh K. Singh,et al.  Glycemic Predictors of Insulin Independence After Total Pancreatectomy With Islet Autotransplantation. , 2017, The Journal of clinical endocrinology and metabolism.

[101]  A. Reiner,et al.  Association of Sickle Cell Trait With Hemoglobin A1c in African Americans , 2017, JAMA.

[102]  Emma English,et al.  Performance of point-of-care HbA1c test devices: implications for use in clinical practice – a systematic review and meta-analysis , 2017, Clinical chemistry and laboratory medicine.

[103]  A. Ferrara,et al.  Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996–2014 , 2017, American journal of obstetrics and gynecology.

[104]  E. Bonifacio,et al.  Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis , 2016, Diabetes.

[105]  C. Bellanné-Chantelot,et al.  Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for? , 2016, Canadian journal of diabetes.

[106]  J. Saunders,et al.  Abnormal glucose tolerance post-gestational diabetes mellitus as defined by the International Association of Diabetes and Pregnancy Study Groups criteria. , 2016, European journal of endocrinology.

[107]  J. Makuc Management of pancreatogenic diabetes: challenges and solutions , 2016, Diabetes, metabolic syndrome and obesity : targets and therapy.

[108]  Heejung Bang,et al.  Comparison of screening scores for diabetes and prediabetes. , 2016, Diabetes research and clinical practice.

[109]  E. Selvin Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference , 2016, Diabetes Care.

[110]  W. Herman Are There Clinical Implications of Racial Differences in HbA1c? Yes, to Not Consider Can Do Great Harm! , 2016, Diabetes Care.

[111]  M. S. Kirkman,et al.  Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions , 2016, Diabetes Care.

[112]  B. Shields,et al.  Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes , 2016, Diabetes Care.

[113]  M. Molitch,et al.  Diabetes Care After Transplant: Definitions, Risk Factors, and Clinical Management. , 2016, The Medical clinics of North America.

[114]  L. Palaniappan,et al.  First Trimester Hemoglobin A1c Prediction of Gestational Diabetes , 2016, American Journal of Perinatology.

[115]  L. Philipson,et al.  GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated , 2016, Acta Diabetologica.

[116]  K. Khunti,et al.  Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis , 2016, The British journal of general practice : the journal of the Royal College of General Practitioners.

[117]  Lorie M. Harper,et al.  Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes , 2016, Obstetrics and gynecology.

[118]  G. Umpierrez,et al.  Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia , 2016, Nature Reviews Endocrinology.

[119]  R. Tamler,et al.  HYPERGLYCEMIA MANAGEMENT IN PATIENTS WITH POSTTRANSPLANTATION DIABETES. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[120]  V. Gebski,et al.  Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus , 2016, BMJ Open.

[121]  W. Herman,et al.  Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States. , 2016, American journal of obstetrics and gynecology.

[122]  J. Larsen,et al.  Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes , 2016 .

[123]  S. Grant,et al.  The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema , 2016, Diabetes Care.

[124]  Lyn Yasumura,et al.  Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening , 2016, Obstetrics and gynecology.

[125]  D. Feig,et al.  Issues With the Diagnosis and Classification of Hyperglycemia in Early Pregnancy , 2015, Diabetes Care.

[126]  Å. Lernmark,et al.  Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association , 2015, Diabetes Care.

[127]  L. Geiss,et al.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. , 2015, JAMA.

[128]  A. Hattersley,et al.  The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study , 2015, The Lancet.

[129]  A. Hartmann,et al.  Emerging treatments for post-transplantation diabetes mellitus , 2015, Nature Reviews Nephrology.

[130]  N. Wintfeld,et al.  Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy , 2015, Diabetes/metabolism research and reviews.

[131]  J. Gross,et al.  Factors affecting A1C in non-diabetic individuals: Review and meta-analysis. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[132]  Kamlesh Khunti,et al.  Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe) , 2015, Diabetes Care.

[133]  M. Rewers,et al.  Incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado youth, 1998-2012. , 2015, JAMA.

[134]  A. Abacı,et al.  Maturity-onset diabetes of the young (MODY): an update , 2015, Journal of pediatric endocrinology & metabolism : JPEM.

[135]  E. Barrett-Connor,et al.  The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. , 2015, The Journal of clinical endocrinology and metabolism.

[136]  Jeremy B Sussman,et al.  Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program , 2015, BMJ : British Medical Journal.

[137]  S. Kahn,et al.  Optimum BMI Cut Points to Screen Asian Americans for Type 2 Diabetes , 2015, Diabetes Care.

[138]  E. Bonifacio,et al.  Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY) , 2015, Diabetes Care.

[139]  Morton B. Brown,et al.  Screening for prediabetes and type 2 diabetes in dental offices , 2015, Journal of public health dentistry.

[140]  T. Brown,et al.  Diagnosing and managing diabetes in HIV-infected patients: current concepts. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[141]  N. Melamed,et al.  The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. , 2015, American journal of obstetrics and gynecology.

[142]  W. Fujimoto,et al.  BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening , 2014, Diabetes Care.

[143]  M. Rice,et al.  Mild Gestational Diabetes Mellitus and Long-Term Child Health , 2014, Diabetes Care.

[144]  S. Fowler,et al.  HbA1c as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial , 2014, Diabetes Care.

[145]  D. Lauderdale,et al.  Reconsidering the age thresholds for type II diabetes screening in the U.S. , 2014, American journal of preventive medicine.

[146]  J. Rowan,et al.  An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes , 2014, Diabetes Care.

[147]  P. Catalano,et al.  Perinatal Outcomes Associated With the Diagnosis of Gestational Diabetes Made by The International Association of the Diabetes and Pregnancy Study Groups Criteria , 2014, Obstetrics and gynecology.

[148]  A. Hattersley,et al.  The diagnosis and management of monogenic diabetes in children and adolescents , 2014 .

[149]  G. Pacini,et al.  Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[150]  D. Feig,et al.  Trends in Incidence of Diabetes in Pregnancy and Serious Perinatal Outcomes: A Large, Population-Based Study in Ontario, Canada, 1996–2010 , 2014, Diabetes Care.

[151]  Jasmin Divers,et al.  Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. , 2014, JAMA.

[152]  P. Heneberg,et al.  Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[153]  A. Åsberg,et al.  Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[154]  N. Emanuele,et al.  The association between glycemic control and clinical outcomes after kidney transplantation. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[155]  A. Tura,et al.  Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus? , 2014, Acta Diabetologica.

[156]  K. Vehik,et al.  Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease , 2014, Pediatric diabetes.

[157]  K. Alberti,et al.  Diagnosis and Classification of Diabetes Mellitus , 2013, Diabetes Care.

[158]  Aaron N. Winn,et al.  Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications , 2013, Diabetes Care.

[159]  J. Coresh,et al.  No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes , 2013, Diabetes Care.

[160]  A. Moran,et al.  New insights into cystic fibrosis-related diabetes in children. , 2013, The lancet. Diabetes & endocrinology.

[161]  I. Lamster,et al.  Dental Findings and Identification of Undiagnosed Hyperglycemia , 2013, Journal of dental research.

[162]  A. Tura,et al.  Glucose Metabolism After Renal Transplantation , 2013, Diabetes Care.

[163]  J. Krischer,et al.  The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients , 2013, Diabetes Care.

[164]  E. Bonifacio,et al.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. , 2013, JAMA.

[165]  A. Hattersley,et al.  Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. , 2013, The Journal of clinical endocrinology and metabolism.

[166]  F. Luan,et al.  Novel views on new-onset diabetes after transplantation: development, prevention and treatment. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[167]  Nan Li,et al.  Evaluation of the Value of Fasting Plasma Glucose in the First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China , 2013, Diabetes Care.

[168]  L. Phillips,et al.  Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk , 2013, Diabetes Care.

[169]  F. Kaufman,et al.  Diabetes Screening With Hemoglobin A1c Versus Fasting Plasma Glucose in a Multiethnic Middle-School Cohort , 2013, Diabetes Care.

[170]  P. Zeitler,et al.  Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children , 2012, International Journal of Pediatric Endocrinology.

[171]  F. Tinahones,et al.  Hemoglobin A1c Versus Oral Glucose Tolerance Test in Postpartum Diabetes Screening , 2012, Diabetes Care.

[172]  C. Beam,et al.  Fall in C-Peptide During First 2 Years From Diagnosis , 2012, Diabetes.

[173]  J. Vendrell,et al.  The usefulness of HbA1c in postpartum reclassification of gestational diabetes , 2012, BJOG : an international journal of obstetrics and gynaecology.

[174]  T. Hannon,et al.  Using hemoglobin A1c for prediabetes and diabetes diagnosis in adolescents: can adult recommendations be upheld for pediatric use? , 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[175]  C. K. Kwan,et al.  Glycated Hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individuals. , 2012, AIDS patient care and STDs.

[176]  J. Ilonen,et al.  Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk , 2012, Diabetologia.

[177]  A. Dyer,et al.  Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria , 2012, Diabetes Care.

[178]  E. Bonifacio,et al.  Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes , 2012, Diabetologia.

[179]  S. Wiegand,et al.  Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database. , 2011, Diabetes research and clinical practice.

[180]  C. Haire,et al.  Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation. , 2011, Transplantation.

[181]  L. Philipson,et al.  Neonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment , 2011, Current diabetes reports.

[182]  Peter C. Austin,et al.  Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk , 2011, Diabetes Care.

[183]  I. Lamster,et al.  Identification of Unrecognized Diabetes and Pre-diabetes in a Dental Setting , 2011, Journal of dental research.

[184]  Elizabeth Selvin,et al.  Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data , 2011, Annals of Internal Medicine.

[185]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[186]  K. Robinson,et al.  Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes , 2010, Diabetes Care.

[187]  D. Williamson,et al.  A1C Level and Future Risk of Diabetes: A Systematic Review , 2010, Diabetes Care.

[188]  Viola Vaccarino,et al.  Glucose-Independent, Black–White Differences in Hemoglobin A1c Levels , 2010, Annals of Internal Medicine.

[189]  Anil Bhansali,et al.  Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. , 2010, The Journal of clinical endocrinology and metabolism.

[190]  B. Shields,et al.  Maturity-onset diabetes of the young (MODY): how many cases are we missing? , 2010, Diabetologia.

[191]  Justin Feigelman,et al.  Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis , 2010, The Lancet.

[192]  H. Bastian,et al.  Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[193]  J. Pankow,et al.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.

[194]  B. Shields,et al.  Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[195]  E. Ford,et al.  Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988–2006 , 2010, Diabetes Care.

[196]  W. Herman,et al.  Association Between Iron Deficiency and A1C Levels Among Adults Without Diabetes in the National Health and Nutrition Examination Survey, 1999–2006 , 2010, Diabetes Care.

[197]  Dwight J Rouse,et al.  A multicenter, randomized trial of treatment for mild gestational diabetes. , 2009, The New England journal of medicine.

[198]  Jeffrey P. Krischer,et al.  Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 , 2009, Diabetes Care.

[199]  A. Hattersley,et al.  The diagnosis and management of monogenic diabetes in children and adolescents , 2009, Pediatric diabetes.

[200]  J. Pilewski,et al.  Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia , 2009, Diabetes Care.

[201]  J. Shaw,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[202]  Patrick E. Georgoff,et al.  A1C Underestimates Glycemia in HIV Infection , 2009, Diabetes Care.

[203]  B. Wolffenbuttel,et al.  Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.

[204]  Kunam S Reddy,et al.  Hyperglycemia during the immediate period after kidney transplantation. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[205]  Bengt Persson,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[206]  Renu Joshi,et al.  Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[207]  S. Fowler,et al.  Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. , 2008, The Journal of clinical endocrinology and metabolism.

[208]  C. Hampe,et al.  Syndromes of ketosis-prone diabetes mellitus. , 2008, Endocrine reviews.

[209]  M. Cappellini,et al.  Glucose-6-phosphate dehydrogenase deficiency , 2008, The Lancet.

[210]  John M. Lachin,et al.  Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program , 2007 .

[211]  A. Sharif,et al.  The Use of Oral Glucose Tolerance Tests to Risk Stratify for New-Onset Diabetes After Transplantation: An Underdiagnosed Phenomenon , 2006, Transplantation.

[212]  Jeannie S. Huang,et al.  Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[213]  E. Hannan,et al.  Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.

[214]  W. Herman,et al.  The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. , 2005, Diabetes care.

[215]  P. Luther,et al.  Pioglitazone in the Management of Diabetes Mellitus after Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[216]  P. Raskin,et al.  Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. , 2004, Archives of internal medicine.

[217]  M. Rewers,et al.  Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. , 2004, Diabetes care.

[218]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[219]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[220]  D. Eckland,et al.  The pharmacokinetics of pioglitazone in patients with impaired renal function. , 2003, British journal of clinical pharmacology.

[221]  W. Herman,et al.  Community-based screening for diabetes in Michigan. , 2003, Diabetes care.

[222]  Catherine Kim,et al.  Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.

[223]  M. Schambelan,et al.  Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV‐1 Infection: Recommendations of an International AIDS Society‐USA Panel , 2002, Journal of acquired immune deficiency syndromes.

[224]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[225]  Merlin C. Thomas,et al.  Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. , 2001, Transplantation.

[226]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[227]  Merlin C. Thomas,et al.  Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes , 2000, BMC nephrology.

[228]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[229]  M. Fantone,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.

[230]  C. Férec,et al.  The hereditary pancreatitis gene maps to long arm of chromosome 7. , 1996, Human molecular genetics.

[231]  D. Coustan,et al.  Criteria for screening tests for gestational diabetes. , 1982, American journal of obstetrics and gynecology.

[232]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[233]  H. L. Wilkerson,et al.  The Effect of Prior Carbohydrate Intake on the Oral Glucose Tolerance Test , 1960, Diabetes.

[234]  J. Conn Interpretation of the glucose tolerance test. The necessity of a stand ard preparatory diet. , 1940 .

[235]  Lara Frommer,et al.  Autoimmune Polyendocrinopathy. , 2019, The Journal of clinical endocrinology and metabolism.

[236]  Atypical Diabetes: Pathophysiology, Clinical Presentations, and Treatment Options , 2018 .

[237]  ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. , 2018, Obstetrics and gynecology.

[238]  P. Reix,et al.  Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard? , 2017, Journal of pediatric endocrinology & metabolism : JPEM.

[239]  J. Gibney,et al.  The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis , 2017, European Journal of Clinical Nutrition.

[240]  L. Philipson,et al.  A Clinical Guide to Monogenic Diabetes , 2016 .

[241]  Betty C. Jung,et al.  [Gestational Diabetes]. , 2016, Journal of midwifery & women's health.

[242]  M. Rickels,et al.  Total pancreatectomy with islet autotransplantation: summary of an NIDDK workshop. , 2015, Annals of surgery.

[243]  Cuilin Zhang,et al.  International Association of Diabetes and Pregnancy Study Group criteria is suitable for gestational diabetes mellitus diagnosis: further evidence from China , 2014, Chinese medical journal.

[244]  Joyce M Lee,et al.  Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia. , 2013, JAMA pediatrics.

[245]  D. Williamson,et al.  Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005-2006. , 2011, American journal of preventive medicine.

[246]  K. Khunti,et al.  Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. , 2011, Lancet.

[247]  E. Lenters-Westra,et al.  Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. , 2010, Clinical chemistry.

[248]  E. Gale Declassifying diabetes , 2006, Diabetologia.

[249]  A. Stolfi,et al.  Insulin and oral agents for managing cystic fibrosis-related diabetes. , 2005, The Cochrane database of systematic reviews.

[250]  SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. , 2004, Controlled clinical trials.

[251]  C. Mahan,et al.  CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY. , 1964, Diabetes.